Dr. Yasmin Abaza, MD

  • Chicago, IL
  • Hematologist and oncologist
NPI1033548383PAC ID8426288184
Medicare services, 2024
13,443
Medicare patients, 2024
257
Part D claims, 2024
245
Publications
40
MIPS score, 2024
95
Practice address
251 E Huron St, Chicago, IL 60611
Practice phone
Call (312) 926-2000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Northwestern Memorial Hospital

Hospital · Chicago, Illinois

See all 9 affiliations

Find Dr. Abaza's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Yasmin Abaza is a hematologist and oncologist in Chicago, Illinois

Dr. Abaza practices at Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare.

Dr. Abaza's NPI, 1033548383, was assigned on November 7, 2013. Dr. Abaza holds Illinois license 036153305.

NPI and contact details
Medicare PAC ID
8426288184
NPI enumeration date
November 7, 2013
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(312) 926-2000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
43
Medical school graduation
2009

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Yasmin Abaza practices at Northwestern Memorial Hospital in Chicago, Illinois

Dr. Abaza's primary practice is Northwestern Memorial Hospital, at 251 E Huron St, Chicago, IL 60611 in Cook County. The practice phone is (312) 926-2000.

Source: Dmand AI Affiliation Data

Dr. Yasmin Abaza is affiliated with 7 sites of care and 2 medical groups

Dr. Abaza's primary practice is Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare. Dr. Abaza is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Abaza to 2 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

See all 9 affiliations for Dr. Abaza

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Yasmin Abaza's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abaza practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Northwestern Memorial HospitalAvailable with a free account
+6 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Abaza practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Northwestern Memorial HealthCare and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Yasmin Abaza is one of 563 hematologists and oncologists in Illinois

Hematology and oncology is Dr. Abaza's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Abaza is licensed in Illinois.

Specialties and state licenses

  • Hematology and oncology, IllinoisPrimaryLicense 036153305 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Abaza

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Yasmin Abaza billed Medicare for 13,443 services in 2024

CMS data shows 13,443 Medicare services from Dr. Abaza across 24 procedure codes in 2024, for 257 Medicare patients. Medicare paid $428,239 for them.

Medicare services, 202413,443
Medicare patients257
Paid by Medicare$428,239
Procedure codes24

Dr. Abaza's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 8,2142024: 12,23949%
Office and hospital visits
2023: 4942024: 57617%
Tests and treatments
2023: 4642024: 4346%
Other services
2023: 02024: 194
Surgery
2023: 362024: 0100%

Where Dr. Abaza's Medicare services took place, 2024

  • In an office13,05297%
  • In a facility3913%

Dr. Abaza compared with the Illinois median for hematologists and oncologists, 2024

  • Dr. Abaza
  • Illinois median
Medicare services
13,443vs 1,05612.7 times
Medicare patients
257vs 2829% below
Part D claims
160vs 32851% below

Medians across 547 hematologists and oncologists in Illinois with Dmand AI profiles that report each measure.

Dr. Abaza's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Abaza

Need commercial claims for Dr. Abaza?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Abaza and other hematologists and oncologists in Illinois.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Yasmin Abaza treated 257 Medicare patients in 2024, average age 74

CMS counts 257 Medicare patients who saw Dr. Abaza in 2024. The largest group is 65 to 74, with 122 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 16% are also on Medicaid. Their average risk score is 3.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abaza's median patient age at 73, with 47% women.

Medicare patients, 2024257
Average age74
Average risk score3.00
Also on Medicaid16%

Dr. Abaza's Medicare patients by age, 2024

Dr. Abaza's Medicare patients by sex, 2024

  • Women12147%
  • Men13653%

Chronic conditions among Dr. Abaza's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol71%
  3. Arthritis45%
  4. Chronic kidney disease36%
  5. Anxiety35%
  6. Cancer35%
  7. Ischemic heart disease34%
  8. Diabetes26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Abaza's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women47%
  • Men52%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Yasmin Abaza wrote 245 Medicare Part D claims in 2024

In 2024, Dr. Abaza wrote 245 Medicare Part D claims for 52 patients. 55% of them were for generic drugs. CMS names the drug for 160 of them, across 7 drugs with 11 or more claims each, at $876,908 in total drug cost. In 2023, CMS named 211 claims across 10 drugs.

Part D claims, 2024245
Drugs named by CMS7
Total drug cost$876,908
Part D patients52

Dr. Abaza's Part D claims by kind of drug, 2024

  • Generic134 claims55%
  • Brand-name111 claims45%

Dr. Abaza's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Abaza's Part D claims, 2024

  • Antibiotics11%28 of 245 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2112024: 16024%

Drugs named by CMS: 7 in 2024, 10 in 2023.

See all prescribing by Dr. Abaza

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Yasmin Abaza scored 95 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Abaza for performance year 2024, reported through an alternative payment model (APM). Dr. Abaza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abaza as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Abaza's MIPS scores, performance year 2024

  • 95of 100Final score
  • 83of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Abaza by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Yasmin Abaza has 40 publications on record

Dmand AI links 40 papers to Dr. Abaza, published from 2014 to 2025. 2022 was the busiest year, with 7. The most frequent topics are Leukemia, Myeloid, Acute, Myelodysplastic Syndromes and Antineoplastic Combined Chemotherapy Protocols. Dr. Abaza has published most often in Am J Hematol. Dr. Abaza's most frequent co-authors are Talha Badar, MD, Vamsi K. Kota, MD and Jessica Kaplan Altman, MD.

Papers40
Years published2014 to 2025

Dr. Abaza's papers by year, 2014 to 2025

Topics Dr. Abaza writes about most

  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Antineoplastic Combined Chemotherapy Protocols
  • Hematopoietic Stem Cell Transplantation
  • Tumor Suppressor Protein p53
  • Clonal Hematopoiesis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Antineoplastic Agents

Dr. Abaza's most frequent co-authors

Recent publications by Dr. Abaza

See all 40 publications and co-authors

See who Dr. Abaza researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Abaza works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Yasmin Abaza received $85,632 in industry payments from 2017 to 2025

CMS Open Payments shows 113 general payments to Dr. Abaza from 16 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 77% of the total. Bristol-Myers Squibb Company paid the most, $18,466.

General payments to Dr. Abaza by program year, 2017 to 2025

General payments to Dr. Abaza by kind, 2017 to 2025

$85.6Kin total
  • Consulting fees$65,84877%
  • Honoraria$7,8989%
  • Travel and lodging$5,6827%
  • Food and beverage$3,2044%
  • Speaker and faculty fees$3,0004%

Companies that paid Dr. Abaza the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Abaza

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Yasmin Abaza's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Yasmin Abaza

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Yasmin Abaza's NPI number?

Dr. Yasmin Abaza's NPI number is 1033548383. It was assigned on November 7, 2013, and it is active in the NPI Registry.

What kind of doctor is Dr. Yasmin Abaza?

Dr. Yasmin Abaza is a hematologist and oncologist in Chicago, Illinois. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Yasmin Abaza practice?

Dr. Abaza practices at 251 E Huron St, Chicago, IL 60611. Dr. Abaza's primary practice is Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare. Dmand AI also links Dr. Abaza to 2 hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group.

What is Dr. Yasmin Abaza's office phone number?

The practice phone on file for Dr. Abaza is (312) 926-2000.

What is Dr. Yasmin Abaza's medical license number?

Dr. Abaza holds Illinois license 036153305.

Which hospitals is Dr. Yasmin Abaza affiliated with?

Dr. Abaza practices at Northwestern Memorial Hospital in Chicago, Illinois. Dr. Abaza is also affiliated with Northwestern Medicine Central DuPage Hospital. Dmand AI links Dr. Abaza to 2 more hospitals.

What medical group is Dr. Yasmin Abaza part of?

Dr. Abaza is linked to Northwestern Medical Faculty Foundation. Dmand AI links Dr. Abaza to 1 more medical group.

Does Dr. Yasmin Abaza accept Medicare?

Yes. CMS data shows Dr. Abaza billed Medicare for 13,443 services in 2024, and Dr. Abaza accepts Medicare assignment.

Does Dr. Yasmin Abaza offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Abaza as offering telehealth services.

What is Dr. Yasmin Abaza's MIPS score?

Dr. Abaza's MIPS final score for performance year 2024 is 95 out of 100, reported through an alternative payment model (APM).

Show 7 more questionsShow fewer questions

How many Medicare patients does Dr. Yasmin Abaza see?

CMS counts 257 Medicare patients who saw Dr. Abaza in 2024, with an average age of 74.

What services does Dr. Yasmin Abaza bill to Medicare?

In 2024, Dr. Abaza's most billed Medicare services were injected or infused drug (J9144), injected or infused drug (J9271) and injected or infused drug (J2919).

What drugs does Dr. Yasmin Abaza prescribe most?

In 2024 Medicare Part D data, Dr. Abaza's most prescribed drugs by claims were Bosulif, Acyclovir and Posaconazole.

Has Dr. Yasmin Abaza received payments from drug or device companies?

CMS Open Payments shows $85,632 in general payments to Dr. Abaza from 16 companies from 2017 to 2025. The largest total came from Bristol-Myers Squibb Company.

How long has Dr. Yasmin Abaza been practicing?

Dr. Abaza graduated from medical school in 2009, 17 years ago.

Does Dr. Yasmin Abaza do research?

Dmand AI links 40 publications to Dr. Abaza, published from 2014 to 2025.

Who does Dr. Yasmin Abaza publish with?

Dr. Abaza's most frequent co-authors are Talha Badar, MD (10 shared papers), Vamsi K. Kota, MD (8 shared papers) and Jessica Kaplan Altman, MD (7 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in Illinois by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)